USP22 and hepatocellular carcinoma: USP22 upregulates the expression of ACC and ACLY by promoting the K48-linked ubiquitination of PPARγ, ultimately fostering lipid accumulation and tumorigenesis in hepatocellular carcinoma cells [172].